Sodium glucose co-transporter inhibitors – A new class of old drugs

Sodium glucose co-transporter (SGLT) inhibitors are a new class of drugs which are used in the pharmacotherapy of Type-II diabetes, which happens to be a major risk factor for developing both micro as well as macro-vascular complications. These drugs inhibit the glucose reabsorption by inhibiting SG...

Descripción completa

Detalles Bibliográficos
Autores principales: Malhotra, Aneeta, Kudyar, Surbhi, Gupta, Anil K., Kudyar, Rattan P., Malhotra, Pavan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Educational Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606572/
https://www.ncbi.nlm.nih.gov/pubmed/26539362
http://dx.doi.org/10.4103/2229-516X.165363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606572/
https://www.ncbi.nlm.nih.gov/pubmed/26539362
http://dx.doi.org/10.4103/2229-516X.165363

Ejemplares similares